"Dream, Dream, Dream! Conduct these dreams into thoughts, and then transform them into action."
- Dr. A. P. J. Abdul Kalam
24 Oct 2019
A new eyedrop can help treat farsightedness which means that people can be saved from the inconvenience of wearing spectacles.
Reversing farsightedness
An Isreali based company Orasis Pharmaceuticals has announced that it has developed a corrective eye drop, CSF -1 that has successfully completed Phase 2b clinical study and has been found to be able to temporarily reverse presbyopia, a very common condition that gradually causes far-sightedness in older adults.
Safe and Effective
The eye drop CSF -1has not only demonstrated remarkable improvement in distance correction but also has displayed an exceptional safety and tolerability profile. This is certainly a significant milestone for people at Orasis who are encouraged with the results and are making relevant preparations for phase 3. According to Orasis CEO Elad Kedar, phase 2b study comprised of 166 participants who participated in a multi-center, double-masked clinical trial that tested the efficacy and safety of the drops.
Kedar said that he and his team are very excited about the consistently positive results and hope to offer a meaningful solution for billions of people living with age-related farsightedness.